U.S. flag

An official website of the United States government

NM_001048174.2(MUTYH):c.563G>A (p.Gly188Glu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jun 17, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000216464.7

Allele description [Variation Report for NM_001048174.2(MUTYH):c.563G>A (p.Gly188Glu)]

NM_001048174.2(MUTYH):c.563G>A (p.Gly188Glu)

Gene:
MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_001048174.2(MUTYH):c.563G>A (p.Gly188Glu)
HGVS:
  • NC_000001.11:g.45332617C>T
  • NG_008189.1:g.12854G>A
  • NM_001048171.2:c.563G>A
  • NM_001048172.2:c.566G>A
  • NM_001048173.2:c.563G>A
  • NM_001048174.2:c.563G>AMANE SELECT
  • NM_001128425.2:c.647G>A
  • NM_001293190.2:c.608G>A
  • NM_001293191.2:c.596G>A
  • NM_001293192.2:c.287G>A
  • NM_001293195.2:c.563G>A
  • NM_001293196.2:c.287G>A
  • NM_001350650.2:c.218G>A
  • NM_001350651.2:c.218G>A
  • NM_012222.3:c.638G>A
  • NP_001041636.2:p.Gly188Glu
  • NP_001041637.1:p.Gly189Glu
  • NP_001041638.1:p.Gly188Glu
  • NP_001041639.1:p.Gly188Glu
  • NP_001121897.1:p.Gly216Glu
  • NP_001121897.1:p.Gly216Glu
  • NP_001280119.1:p.Gly203Glu
  • NP_001280120.1:p.Gly199Glu
  • NP_001280121.1:p.Gly96Glu
  • NP_001280124.1:p.Gly188Glu
  • NP_001280125.1:p.Gly96Glu
  • NP_001337579.1:p.Gly73Glu
  • NP_001337580.1:p.Gly73Glu
  • NP_036354.1:p.Gly213Glu
  • LRG_220t1:c.647G>A
  • LRG_220:g.12854G>A
  • LRG_220p1:p.Gly216Glu
  • NC_000001.10:g.45798289C>T
  • NM_001128425.1:c.647G>A
  • NR_146882.2:n.791G>A
  • NR_146883.2:n.640G>A
Protein change:
G188E
Links:
dbSNP: rs768553551
NCBI 1000 Genomes Browser:
rs768553551
Molecular consequence:
  • NM_001048171.2:c.563G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048172.2:c.566G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048173.2:c.563G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048174.2:c.563G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128425.2:c.647G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293190.2:c.608G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293191.2:c.596G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293192.2:c.287G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293195.2:c.563G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293196.2:c.287G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350650.2:c.218G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350651.2:c.218G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012222.3:c.638G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_146882.2:n.791G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_146883.2:n.640G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000275359Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Jun 17, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000680454GeneID Lab - Advanced Molecular Diagnostics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Sep 7, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
Latinogermlineno1not providednot providednot providednot providedclinical testing

Citations

PubMed

Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3.

Dallosso AR, Dolwani S, Jones N, Jones S, Colley J, Maynard J, Idziaszczyk S, Humphreys V, Arnold J, Donaldson A, Eccles D, Ellis A, Evans DG, Frayling IM, Hes FJ, Houlston RS, Maher ER, Nielsen M, Parry S, Tyler E, Moskvina V, Cheadle JP, et al.

Gut. 2008 Sep;57(9):1252-5. doi: 10.1136/gut.2007.145748. Epub 2008 May 30.

PubMed [citation]
PMID:
18515411

Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.

Nielsen M, Joerink-van de Beld MC, Jones N, Vogt S, Tops CM, Vasen HF, Sampson JR, Aretz S, Hes FJ.

Gastroenterology. 2009 Feb;136(2):471-6. doi: 10.1053/j.gastro.2008.10.056. Epub 2008 Oct 30.

PubMed [citation]
PMID:
19032956
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV000275359.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.G216E variant (also known as c.647G>A), located in coding exon 8 of the MUTYH gene, results from a G to A substitution at nucleotide position 647. The glycine at codon 216 is replaced by glutamic acid, an amino acid with similar properties. This variant has been confirmed in trans with a MUTYH founder mutation in a patient diagnosed with three separate primary colorectal cancers at age 38 (Morak M et al. Clin Genet, 2010 Oct;78:353-63). This variant has also been detected in conjunction with a MUTYH founder mutation in an individual with multiple colorectal adenomas (Dallosso AR et al. Gut 2008 Sep; 57(9):1252-5; Vogt S et al. Gastroenterology. 2009 Dec;137(6):1976-85.e1-10) and in 1/257 patients with MUTYH-associated polyposis (Nielsen M et al. Gastroenterology, 2009 Feb;136:471-6). Additionally, this variant has been identified in at least one patient with a personal or family history of breast and/or ovarian cancer (Maxwell KN et al. Am J Hum Genet. 2016 May 5;98(5):801-17). Based on internal structural analysis using published crystal structures, p.G216E is structurally deleterious (Ambry internal data). Of note, this alteration is also designated as p.G213E in published literature. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneID Lab - Advanced Molecular Diagnostics, SCV000680454.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Latino1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024